PROCAN SR 500 MG
PROCAINAMIDE HYDROCHLORIDE : 500 MG · DIN 00638676 · ERFA CANADA 2012 INC
Health Canada status: CANCELLED POST MARKET
What is PROCAN SR?
PROCAN SR 500 MG contains PROCAINAMIDE HYDROCHLORIDE : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 00638676, held by ERFA CANADA 2012 INC, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Jun-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PROCAN SR used for?
PROCAN SR (Procainamide Hydrochloride Sustained-Release Tablets) is indicated for the treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. PROCAN SR may also be used for the treatment of patients with documented symptomatic ventricular arrhythmias when the symptoms are of sufficient severity to require treatment. PROCAN SR is also indicated in the treatment of atrial fibrillation, particularly if the condition is of recent development and the treatments of choice cannot be used or are ineffective. The drug may also be used in paroxysmal atrial tachycardia which cannot be controlled by reflex stimulation or by other measures.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00638676 |
|---|---|
| Brand name | PROCAN SR |
| Generic / active ingredient | PROCAINAMIDE HYDROCHLORIDE : 500 MG |
| Manufacturer | ERFA CANADA 2012 INC |
| Strength | 500 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C01BA02 PROCAINAMIDE |
| AHFS class | 24:04.04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 05-Jun-2015 |
| Original market date | 1985-12-31 00:00:00 |
How is it stored and handled?
Protect from moisture. Store at controlled room temperature, 15-30 °C.
How is it supplied?
Bottles of 100.
What can be used instead?
Other Canadian products sharing ATC code C01BA02 PROCAINAMIDE. 1 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PROCAINAMIDE HYDROCHLORIDE INJECTION USP | 100 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02184486 |
| APO-PROCAINAMIDE CAP 250MG | 250 MG | CAPSULE | APOTEX INC | CANCELLED POST MARKET | DIN 00713325 |
| APO-PROCAINAMIDE CAP 375MG | 375 G | CAPSULE | APOTEX INC | CANCELLED POST MARKET | DIN 00713333 |
| APO-PROCAINAMIDE CAP 500MG | 500 MG | CAPSULE | APOTEX INC | CANCELLED POST MARKET | DIN 00713341 |
| PROCAINAMIDE-250 CAP 250MG | 250 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00731382 |
| PROCAINAMIDE-375 CAP 375MG | 375 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00731390 |
| PROCAINAMIDE-500 CAP 500MG | 500 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00728268 |
| PROCAN SR | 250 MG | TABLET (EXTENDED-RELEASE) | SEARCHLIGHT PHARMA INC | CANCELLED POST MARKET | DIN 00638692 |
| PROCAN SR | 750 MG | TABLET (EXTENDED-RELEASE) | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00638684 |
| PRONESTYL CAP 250MG | 250 MG | CAPSULE | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 00029076 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.